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Thromboses r e l a t e d t o umbilical a r t e r y c a t h e t e r s (UA caths) c o n t r i b u t e s i g n i f i c a n t morbidity t o neonatal i n t e n s i v e support. This prospective randomized study was begun t o evaluate the e f f i c a c y of prophylactic heparinization i n t h e prevention of U A c a t h r e l a t e d thrombi. To d a t e , 19 preterm i n f a n t s have been assigned t o 1 ) therapeutic heparinization (20-25~/kg/hr) or 2) infusions of 1-2Ulml heparin ( c o n t r o l s ) . Using lOMHz u l t r asound (US) thrombi of 1-18 mm were imaged 1-7 days a f t e r insert i o n of a U A cath. Pulsed doppler v e l o c i t y i n the c a t h e t e r i z e d i l i a c was twice t h a t of the uncatheterized i l i a c and increased t o 2311 one t o four days p r i o r t o t h e appearance of a thrombus on US. Aortography was performed t o corroborate US and doppler findings. With these s t u d i e s , thrombi were detected i n 1/11 heparinized and 418 c o n t r o l i n f a n t s (p <0.05). Heparinization r e s u l t e d i n a %! Laidlaw c l o t t i n g time of 153 sec (Nz100) and heparin l e v e l s of 0.2-0.6UIml without complications including I C H . Baseline p r o t e i n C (pro C) l e v e l s were s i m i l a r i n each group and lower than i n term newborns (0.25 v s 0.32U/ml). By day 6 , no e f f e c t of heparin was noted on l e v e l s of AT-111 (0.38 v s 0.37U/ml) o r pro C (0.36 v s 0.37U/ml), while p l a t e l e t counts were higher i n heparinized i n f a n t s (247 vs 164 x l o 9 / l ) . The heparinized i n f a n t s had lower blood v e l o c i t i e s i n the cathet e r i z e d i l i a c a r t e r y (48 vs 95 cmlsec on day 6 ) . Therapeutic heparinization i n h i b i t s thrombus propagation along U A c a t h e t e r s r e s u l t i n g i n l e s s obstruction t o blood flow. In p e r s i s t e n t pulmonary hypertension of the newborn (PPHN) , pulmonary a r t e r y pressure (PAP) exceeds a o r t i c pressure (AOP). Pharmacologic therapy directed a t s e l e c t i v e l y reducing PAP more than AOP has been largely unsuccessful. W e have developed an animal model of neonatal pulmonary hypertension, and have pharmacologically induced s e l e c t i v e elevation of AOP as an a l t e r n a t i v e approach t o PPHN. Neonatal p i g l e t s (n=6) were intubated, anaesthetized, and v e n t i l a t e d . AOP, PAP, and cardiac output (CO) were measured d i r e c t l y and continuously.
Pulmonary hypertension was induced by intravenous infusion of serotype l b Group B Beta Streptococci (GBS) @ approximately 107 Organisms/kg/min. During GBS infusion, PAP rose by 131 +/-60% (S.D.), while AOP rose by 4 +/-11%. CO f e l l by 34 +/-134 in response t o GBS. Phenylephrine (PE) was then infused i n t o the s e p t i c p i g l e t @ 0.3 mg/kg/dose.
After PE, AOP rose by 29 +/-13% from post-GBS/pre-PE values, while PAP rose by only 3 +/-7%. CO f e l l by 29 +/-19% a f t e r PE.
Conclusions: 1) Neonatal pulmonary hypertension can be modeled by GBS infusion in the p i g l e t .
2) PE infusion s e l e c t i v e l y e l e v a t e s AOP more than PAP in the s e p t i c p i g l e t . 3) S e l e c t i v e elevation of systemic blood pressure may be a f e a s i b l e therapeutic s t r a t e g y in human infants with PPHN. Duplex ultrasonography combines a range-gated Doppler flowmeter with r e a l time 2-dimensional ultrasound imaging t o y i e l d measurements of blood v e l o c i t y and cross-sectional a r e a . Flow i s c a l c u l a t e d using t h e equation F = V * A where V = v e l o c i t y and A = cross-sectional area. To evaluate t h e v a l i d i t y of t h i s technique we obtained measurements i n an i n v i t r o model of p u l s a t i l e flow ( 1 ) and i n t h e dog using t h e carb r a c h i a l a r t e r i e s . Flow c a l c u l a t i o n s of mean peak flow were compared t o d i r e c t (volumetric) measurements ( n = 50) of mean flow i n t h e i n v i t r o model and i n d i r e c t (surgically-placed electromagnetic flo= measurements ( n = 40) of mean flow i n t h e dog. The c o r r e l a t i o n was 0.90 with t h e i n v i t r o model and 0.80 with t h e dog model. We then measured mean peak blood flow i n t h e a n t e r i o r c e r e b r a l a r t e r y of 13 neonates through t h e a n t e r i o r f o n t a n e l l e . Flow ranged from 0.87 t o 10.39 cc/min (mean 3.88 cc/min). W e conclude t h a t noninvasive measurement of blood flow with duplex ultrasonography i s comparable t o other established d i r e c t , invasive methods, and may be u s e f u l i n t h e evaluation of t h e i n t r a c r a n i a l c i r c u l a t i o n i n t h e neonate.
MEASUREMENT OF MEAN PEAK BLOOD FLOW USING
1. Miles, R . : Transmission of v i b r a t i o n from simulated a r t e r i a l s t e n o s i s . Masters Thesis, Iowa S t a t e University, 1976. It has been suspected that nutrition during pregnancy might counteract the adverse effects of smoking on birthweight (BWT). In our previous prospective studies of -2100 mothers, 47% were smokers who had 63% of the babies with BWT below our median (3300g). A prospective, randomized, controlled trial of a food supplement (WIC) from 19 weeks to term in 410 of these free-living mothers led to increased mean BWT +91g (p=0.039), which was greater in smokers (+115g, p=0.034), taking into account sex, gestational age, race, prenatal visits. In 288 motherbaby pairs multiple regression analysis revealed an interaction between maternal midpregnancy (19 weeks) plasma levels of cholesterol (chol), B carotene (BC) and smoking on BWT (p=0.017). Prospective data on the interactive effects of BC, chol and smoking on BWT apparently have not previously been noted. High BC (> 116 ]lg/dl) and low chol levels (< 150 mgldl) were associated with significantly larger babies (+ -5OOg) in the smokers. If BC levels remained high from 19 to 36 weeks of gestation, heavy smokers delivered large babies. If BC levels decreased, the babies were small. In nonsmokers, no interaction between these nutrients on BWT was detected, but BWT was -300g more with higher chol, i.e., from 116 to 272 mg/dl a t midpregnancy, at all levels of BC. We conclude that certain plasma levels of 6 carotene and cholesterol in smokers might counteract the adverse effect of smoking on fetal growth. Human prematures have low l e v e l s of Vit. E. While supplement a t i o n with Vit.E seems d e s i r a b l e , t h i s may lead t o decreased k i l l i n g of ingested microorganisms by neutrophi 1s (NP), as suggested by recent r e p o r t s , thus f u r t h e r impairing newborn host defense. W e studied the e f f e c t s of oral dl &Tocopherol (o\T) administration t o prematures on N P functions i n a randomized doubls blind placebo(P) controlled t r i a l . n I and P roups were of comparable gestational age( ~: 3 2 ' 2 . 2 ;~: 3 2 -1 . 6 wksg,birthweight,race, sex,Apgar score, and mode of delivery; 42 babies were in theMT group,31 in P group. W e studied serum v i t E,polyunsaturated f a t t y acid composi tion,H202 induced hemolysis,ingestion(Phag)and k i lling(K) of S. Aureus 502-A(SA), by NP.At a dose of 15mg/kg/day,m T did not lead t o a s i g n i f i c a n t r i s e i n v i t E 1evels;Phag.and K were unchanged. A second and t h i r d group were given 50 and 10Omq
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dT/kg/day po respective1y:in these groups serum Vit E l e v e l s r o s e s i g n i f i c a n t l y over the level in P group and reached levels)/0:8 mg% in 77% of babies. Hz02 induced hemolysis decreased concomlta n t l y . Phag. and K were unaffected however. BothdT and P groups had s i m i l a r values which did not d i f f e r s i g n i f i c a n t l y , regardless of the time i n t e r v a l a f t e r s t a r t bf therapy,at which the samples were taken. Our data s u g g e s t -t h a t supplementation of prematures w i t Shulman, Ram Yogev. Northwestern Univ. Med. School, Children's Mem. Hosp., Dept. of P e d i a t r i c s , Chicago. Multiple a n t i b i o t i c s t r a t e g i e s have been used i n attempts t o e r a d i c a t e GBS from colonized i n f a n t s and women. However, no chemoprophylactic regimen has been successful i n r e l i a b l y eliminating GBS c a r r i a g e . Because rifampin (Rif) has been u t i l i z e d succ e s s f u l l y t o terminate nasopharyngeal colonization with meningococci, H . influenzae, o r S. pyo enes, we t e s t e d the i n v i t r o sens i t i v i t y of GBS t o Rif and the z b i l i t y of Rif t o e l i z n a~~ from n a s a l l y colonized i n f a n t r a t s . The MIC of Rif f o r 18 s t r a i n s of type 111 GBS ranged from 0.1-0.4 ug/ml. Atraumatic nasal inocu l a t i o n of 1-2 day-old r a t s with 10'-10~ colony forming u n i t s of GBS (MIC = 0.1 pg/ml) twice d a i l y f o r 4 days resulted i n 100% GBS c a r r i a g e f o r a t l e a s t 7 days. Colonized animals were divided i n t o 4 treatment groups: 1) s a l i n e , 2) o r a l Rif (20 rnglkgldose q 1 2 h r s x 4 days), 3) i n t r a p e r i t o n e a l (IP) p e n i c i l l i n (PCN) (50,000 units/kg/dose q 12 h r s x 4 days), or 4) IP PCN & o r a l R i f . A l l 73 s a l i n e c o n t r o l s and 26/29 PCN-treated animals had continued GBS nasal c a r r i a g e 36 hours a f t e r completion of therapy (p=NS). In c o n t r a s t , only 10137 Rif-treated animals and 5/42 PCN & Rift r e a t e d animals remained GBS-positive. No rifampin-resistant CBS emerged. Rif o r PCN & Rif i s s i g n i f i c a n t l y more e f f e c t i v e i n eradicating GBS c a r r i a g e , compared t o s a l i n e or PCN (p<O.0001). These data demonstrate t h a t , unlike PCN, Rif (with or without PCN) i s e f f e c t i v e i n eliminating GBS from nasally colonized inf a n t r a t s . C l i n i c a l t r i a l s with rifnmpin appear indicated.
